BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9335443)

  • 1. Diabetes mellitus and the risk of primary liver cancer.
    La Vecchia C; Negri E; Decarli A; Franceschi S
    Int J Cancer; 1997 Oct; 73(2):204-7. PubMed ID: 9335443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history and the risk of liver, gallbladder, and pancreatic cancer.
    Fernandez E; La Vecchia C; D'Avanzo B; Negri E; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):209-12. PubMed ID: 8019368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus and colorectal cancer risk.
    La Vecchia C; Negri E; Decarli A; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1007-10. PubMed ID: 9419395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cirrhosis and the risk of primary liver cancer.
    La Vecchia C; Negri E; Cavalieri d'Oro L; Franceschi S
    Eur J Cancer Prev; 1998 Aug; 7(4):315-20. PubMed ID: 9806120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of diabetes mellitus and cancer risk.
    La Vecchia C; Negri E; Franceschi S; D'Avanzo B; Boyle P
    Br J Cancer; 1994 Nov; 70(5):950-3. PubMed ID: 7947103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history of liver cancer and hepatocellular carcinoma.
    Turati F; Edefonti V; Talamini R; Ferraroni M; Malvezzi M; Bravi F; Franceschi S; Montella M; Polesel J; Zucchetto A; La Vecchia C; Negri E; Decarli A
    Hepatology; 2012 May; 55(5):1416-25. PubMed ID: 22095619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive epidemiology of bile duct carcinoma in Osaka.
    Ikeda A; Miyashiro I; Nakayama T; Ioka A; Tabuchi T; Ito Y; Tsukuma H
    Jpn J Clin Oncol; 2013 Nov; 43(11):1150-5. PubMed ID: 24014885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study.
    Matsuo M
    Kurume Med J; 2003; 50(3-4):91-8. PubMed ID: 14768471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.
    Montella M; Polesel J; La Vecchia C; Dal Maso L; Crispo A; Crovatto M; Casarin P; Izzo F; Tommasi LG; Talamini R; Franceschi S
    Int J Cancer; 2007 Apr; 120(7):1555-9. PubMed ID: 17205531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and endometrial cancer: an Italian case-control study.
    Parazzini F; La Vecchia C; Negri E; Riboldi GL; Surace M; Benzi G; Maina A; Chiaffarino F
    Int J Cancer; 1999 May; 81(4):539-42. PubMed ID: 10225441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical history and primary liver cancer.
    La Vecchia C; Negri E; D'Avanzo B; Boyle P; Franceschi S
    Cancer Res; 1990 Oct; 50(19):6274-7. PubMed ID: 2400990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between metabolic syndrome and hepatobiliary cancers: A case-control study.
    Menon S; Mathew R
    Indian J Gastroenterol; 2019 Feb; 38(1):61-68. PubMed ID: 30628006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess risk of primary liver cancer in patients with diabetes mellitus.
    Adami HO; Chow WH; Nyrén O; Berne C; Linet MS; Ekbom A; Wolk A; McLaughlin JK; Fraumeni JF
    J Natl Cancer Inst; 1996 Oct; 88(20):1472-7. PubMed ID: 8841022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attributable risks for hepatocellular carcinoma in northern Italy.
    Braga C; La Vecchia C; Negri E; Franceschi S
    Eur J Cancer; 1997 Apr; 33(4):629-34. PubMed ID: 9274446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
    Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
    Hassan MM; Hwang LY; Hatten CJ; Swaim M; Li D; Abbruzzese JL; Beasley P; Patt YZ
    Hepatology; 2002 Nov; 36(5):1206-13. PubMed ID: 12395331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female hormone utilisation and risk of hepatocellular carcinoma.
    Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
    Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.